Clinical trials
Kidney Failure, Chronic trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 11 |
| 2011 | 2 |
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 5 |
| 2015 | 3 |
| 2016 | 6 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 34 |
| Unknown status | 20 |
| Recruiting | 3 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seoul National University Hospital | 7 |
| Yonsei University | 7 |
| Kyungpook National University Hospital | 4 |
| Kyunghee University Medical Center | 3 |
| Samsung Medical Center | 3 |
| Cara Therapeutics, Inc. | 2 |
| Daewon Pharmaceutical Co., Ltd. | 2 |
| Ewha Womans University | 2 |
| GlaxoSmithKline | 2 |
| Korea Institute of Oriental Medicine | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Failure, Chronic | 61 |
| Renal Insufficiency, Chronic | 12 |
| Anemia | 4 |
| Diabetes Mellitus | 3 |
| Dwarfism, Pituitary | 2 |
| Pruritus | 2 |
| Renal Insufficiency | 2 |
| Turner Syndrome | 2 |
| Atherosclerosis | 1 |
| COVID-19 | 1 |
Trials
Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.